Caroline Blackie is an internationally recognized clinical and scientific expert in the field of dry eye with specific focus on meibomian gland dysfunction. She has authored and published over 40 scientific articles in this area. She currently serves as the Medical Director for Ocular Surface Disease for Johnson and Johnson Vision, providing medical and scientific leadership to drive and shape innovation in this therapeutic area.  Dr. Blackie joined Johnson and Johnson Vision after 12 years with TearScience. At TearScience, she served on the small team of individuals who imagined, designed, developed, tested, and brought to market all of the TearScience Products. Passionate about the patient experience, she also successfully divided her time between clinical research and development and private practice, accruing approximately 20 years of direct patient care experience in her career.  Her years in direct clinical care, fuel her desire to elevate and transform the standard of care towards a more proactive approach to ocular surface health.

Brian Regan is a growth, launch and turnaround sales and marketing executive with history delivering innovation for patient care, revenue growth and significant investor value. Skilled in leadership of sales and marketing, business strategy, market research, KOL development, customer service, CRM, and metrics reflecting progress on KPI’s.